Cancer/testis antigens FBXO39 and CEP55 expression correlates with survival in GBM patients - Parisa Azimi; Maryam Bazrgar; Taravat Yazdanian; Mehdi Totonchi; Abolhassan Ahmadiani (PLoS ONE, 2025)